Explore
Trendline
Cava Founders Accused of $2.2 Billion Insider Trading Scheme
Cava Founders Accused of $2.2 Billion Insider Trading Scheme
Read More
Trendline
GitLab Seeks Lead SEC Analyst to Enhance Financial Reporting
GitLab Seeks Lead SEC Analyst to Enhance Financial Reporting
Read More
AP News
More drops for chipmakers weigh on Wall Street
Most of Wall Street is rising, even as stocks of computer chipmakers continue to tumble worldwide
Read More
Trendline
MapLight's Schizophrenia Drug Fails to Surpass Cobenfy in Phase 2 Trial, Leading to Stock Decline
MapLight's Schizophrenia Drug Fails to Surpass Cobenfy in Phase 2 Trial, Leading to Stock Decline
Read More
Trendline
UPS Reports Strong Q2 2026 Earnings, Raises Full-Year Revenue Outlook
UPS Reports Strong Q2 2026 Earnings, Raises Full-Year Revenue Outlook
Read More
Trendline
Micron Technology Faces Stock Decline Amidst Chinese Rival's IPO Success
Micron Technology Faces Stock Decline Amidst Chinese Rival's IPO Success
Read More
Trendline
Rosen Law Firm Urges GRAIL Investors to Act Before Class Action Deadline
Rosen Law Firm Urges GRAIL Investors to Act Before Class Action Deadline
Read More
Trendline
Intuit Faces Securities Fraud Lawsuit Over Misleading Statements on TurboTax Business
Intuit Faces Securities Fraud Lawsuit Over Misleading Statements on TurboTax Business
Read More
Trendline
Temenos Reports Q2-26 Results with Reconfirmed FY-26 Guidance Amidst Strong Pipeline
Temenos Reports Q2-26 Results with Reconfirmed FY-26 Guidance Amidst Strong Pipeline
Read More
Trendline
Morgan Stanley Highlights AI Adoption as Key to Profit Growth for U.S. Companies
Morgan Stanley Highlights AI Adoption as Key to Profit Growth for U.S. Companies
Read More
Trendline
Polar Asset Management Reduces Stake in Taiwan Semiconductor Manufacturing
Polar Asset Management Reduces Stake in Taiwan Semiconductor Manufacturing
Read More
Trendline
Capricor Criticizes FDA's Use of 'Obsolete' Analysis in Deramiocel Review, Stock Plummets
Capricor Criticizes FDA's Use of 'Obsolete' Analysis in Deramiocel Review, Stock Plummets
Read More